A 0 1 0 1 O
QT 2 4 2 4 O
interval 5 13 5 13 O
corrected 14 23 14 23 O
for 24 27 24 27 O
heart 28 33 28 33 O
rate 34 38 34 38 O
using 39 44 39 44 O
the 45 48 45 48 O
Bazett 49 55 49 55 B-clinical_variable
's 55 57 55 57 I-clinical_variable
formula 58 65 58 65 I-clinical_variable
QTcB 66 70 66 70 I-clinical_variable
> 71 72 71 72 O
= 72 73 72 73 O
480 74 77 74 77 B-lower_bound
msec 78 82 78 82 I-lower_bound

Able 0 4 83 87 O
to 5 7 88 90 O
swallow 8 15 91 98 O
and 16 19 99 102 O
retain 20 26 103 109 O
orally 27 33 110 116 B-treatment
- 33 34 116 117 I-treatment
administered 34 46 117 129 I-treatment
medication 47 57 130 140 I-treatment
and 58 61 141 144 O
does 62 66 145 149 O
not 67 70 150 153 O
have 71 75 154 158 O
any 76 79 159 162 O
clinically 80 90 163 173 O
significant 91 102 174 185 O
gastrointestinal 103 119 186 202 B-chronic_disease
abnormalities 120 133 203 216 I-chronic_disease
that 134 138 217 221 O
may 139 142 222 225 O
alter 143 148 226 231 O
absorption 149 159 232 242 O
such 160 164 243 247 O
as 165 167 248 250 O
malabsorption 168 181 251 264 B-chronic_disease
syndrome 182 190 265 273 I-chronic_disease
or 191 193 274 276 O
major 194 199 277 282 B-treatment
resection 200 209 283 292 I-treatment
of 210 212 293 295 I-treatment
the 213 216 296 299 I-treatment
stomach 217 224 300 307 I-treatment
or 225 227 308 310 I-treatment
bowels 228 234 311 317 I-treatment

Absolute 0 8 318 326 B-clinical_variable
neutrophil 9 19 327 337 I-clinical_variable
count 20 25 338 343 I-clinical_variable
( 26 27 344 345 I-clinical_variable
ANC 27 30 345 348 I-clinical_variable
) 30 31 348 349 I-clinical_variable
> 32 33 350 351 O
= 33 34 351 352 O
1.2 35 38 353 356 B-lower_bound
x 39 40 357 358 I-lower_bound
10 41 43 359 361 I-lower_bound
^ 43 44 361 362 I-lower_bound
9 44 45 362 363 I-lower_bound
/ 45 46 363 364 I-lower_bound
L 46 47 364 365 I-lower_bound

Active 0 6 366 372 O
hepatitis 7 16 373 382 B-chronic_disease
B 17 18 383 384 I-chronic_disease
virus 19 24 385 390 I-chronic_disease
( 25 26 391 392 I-chronic_disease
HBV 26 29 392 395 I-chronic_disease
) 29 30 395 396 I-chronic_disease
, 30 31 396 397 O
or 32 34 398 400 O
hepatitis 35 44 401 410 B-chronic_disease
C 45 46 411 412 I-chronic_disease
virus 47 52 413 418 I-chronic_disease
( 53 54 419 420 I-chronic_disease
HCV 54 57 420 423 I-chronic_disease
) 57 58 423 424 I-chronic_disease
infection 59 68 425 434 O

All 0 3 435 438 O
patients 4 12 439 447 O
must 13 17 448 452 O
have 18 22 453 457 O
completed 23 32 458 467 O
any 33 36 468 471 O
prior 37 42 472 477 B-treatment
chemotherapy 43 55 478 490 I-treatment
, 55 56 490 491 O
targeted 57 65 492 500 B-treatment
therapy 66 73 501 508 I-treatment
, 73 74 508 509 O
radiotherapy 75 87 510 522 B-treatment
( 88 89 523 524 O
unless 89 95 524 530 O
palliative 96 106 531 541 O
doses 107 112 542 547 O
which 113 118 548 553 O
must 119 123 554 558 O
be 124 126 559 561 O
discussed 127 136 562 571 O
with 137 141 572 576 O
study 142 147 577 582 O
principal 148 157 583 592 O
investigator 158 170 593 605 O
) 170 171 605 606 O
, 171 172 606 607 O
surgery 173 180 608 615 B-treatment
, 180 181 615 616 O
anti 182 186 617 621 B-treatment
- 186 187 621 622 I-treatment
angiogenic 187 197 622 632 I-treatment
therapy 198 205 633 640 I-treatment
or 206 208 641 643 O
interferon 209 219 644 654 B-treatment
> 220 221 655 656 O
= 221 222 656 657 O
28 223 225 658 660 B-lower_bound
days 226 230 661 665 I-lower_bound
before 231 237 666 672 I-lower_bound
study 238 243 673 678 O
entry 244 249 679 684 O

All 0 3 685 688 O
prior 4 9 689 694 B-treatment
treatment 10 19 695 704 I-treatment
- 19 20 704 705 I-treatment
related 20 27 705 712 I-treatment
toxicities 28 38 713 723 I-treatment
must 39 43 724 728 O
be 44 46 729 731 O
Common 47 53 732 738 B-clinical_variable
Terminology 54 65 739 750 I-clinical_variable
Criteria 66 74 751 759 I-clinical_variable
for 75 78 760 763 I-clinical_variable
Adverse 79 86 764 771 I-clinical_variable
Events 87 93 772 778 I-clinical_variable
( 94 95 779 780 I-clinical_variable
CTCAE 95 100 780 785 I-clinical_variable
) 100 101 785 786 I-clinical_variable
version 102 109 787 794 I-clinical_variable
4.0 110 113 795 798 I-clinical_variable
grade 114 119 799 804 I-clinical_variable
= 120 121 805 806 O
< 121 122 806 807 O
1 123 124 808 809 B-upper_bound
( 125 126 810 811 O
except 126 132 811 817 O
alopecia 133 141 818 826 B-chronic_disease
) 141 142 826 827 O
at 143 145 828 830 O
the 146 149 831 834 O
time 150 154 835 839 O
of 155 157 840 842 O
enrollment 158 168 843 853 O

Animal 0 6 854 860 O
reproductive 7 19 861 873 O
studies 20 27 874 881 O
have 28 32 882 886 O
not 33 36 887 890 O
been 37 41 891 895 O
conducted 42 51 896 905 O
with 52 56 906 910 O
trametinib 57 67 911 921 B-treatment
; 67 68 921 922 O
therefore 69 78 923 932 O
, 78 79 932 933 O
the 80 83 934 937 O
study 84 89 938 943 O
drug 90 94 944 948 O
must 95 99 949 953 O
not 100 103 954 957 O
be 104 106 958 960 O
administered 107 119 961 973 O
to 120 122 974 976 O
pregnant 123 131 977 985 B-pregnancy
women 132 137 986 991 B-gender
or 138 140 992 994 O
nursing 141 148 995 1002 O
mothers 149 156 1003 1010 O
; 156 157 1010 1011 O
women 158 163 1012 1017 O
of 164 166 1018 1020 O
childbearing 167 179 1021 1033 O
potential 180 189 1034 1043 O
should 190 196 1044 1050 O
be 197 199 1051 1053 O
advised 200 207 1054 1061 O
to 208 210 1062 1064 O
avoid 211 216 1065 1070 O
pregnancy 217 226 1071 1080 B-pregnancy
and 227 230 1081 1084 O
use 231 234 1085 1088 B-contraception_consent
effective 235 244 1089 1098 I-contraception_consent
methods 245 252 1099 1106 I-contraception_consent
of 253 255 1107 1109 I-contraception_consent
contraception 256 269 1110 1123 I-contraception_consent
; 269 270 1123 1124 O
men 271 274 1125 1128 O
with 275 279 1129 1133 O
a 280 281 1134 1135 O
female 282 288 1136 1142 B-gender
partner 289 296 1143 1150 O
of 297 299 1151 1153 O
childbearing 300 312 1154 1166 O
potential 313 322 1167 1176 O
must 323 327 1177 1181 O
have 328 332 1182 1186 O
either 333 339 1187 1193 O
had 340 343 1194 1197 O
a 344 345 1198 1199 O
prior 346 351 1200 1205 B-treatment
vasectomy 352 361 1206 1215 I-treatment
or 362 364 1216 1218 O
agree 365 370 1219 1224 B-contraception_consent
to 371 373 1225 1227 I-contraception_consent
use 374 377 1228 1231 I-contraception_consent
effective 378 387 1232 1241 I-contraception_consent
contraception 388 401 1242 1255 I-contraception_consent
; 401 402 1255 1256 O
if 403 405 1257 1259 O
a 406 407 1260 1261 O
female 408 414 1262 1268 B-gender
patient 415 422 1269 1276 I-gender
or 423 425 1277 1279 O
a 426 427 1280 1281 O
female 428 434 1282 1288 O
partner 435 442 1289 1296 O
of 443 445 1297 1299 O
a 446 447 1300 1301 O
patient 448 455 1302 1309 O
becomes 456 463 1310 1317 O
pregnant 464 472 1318 1326 O
while 473 478 1327 1332 O
the 479 482 1333 1336 O
patient 483 490 1337 1344 O
receives 491 499 1345 1353 O
trametinib 500 510 1354 1364 O
, 510 511 1364 1365 O
the 512 515 1366 1369 O
potential 516 525 1370 1379 O
hazard 526 532 1380 1386 O
to 533 535 1387 1389 O
the 536 539 1390 1393 O
fetus 540 545 1394 1399 O
should 546 552 1400 1406 O
be 553 555 1407 1409 O
explained 556 565 1410 1419 O
to 566 568 1420 1422 O
the 569 572 1423 1426 O
patient 573 580 1427 1434 O
and 581 584 1435 1438 O
partner 585 592 1439 1446 O
( 593 594 1447 1448 O
as 594 596 1448 1450 O
applicable 597 607 1451 1461 O
) 607 608 1461 1462 O

Any 0 3 1463 1466 O
condition 4 13 1467 1476 O
or 14 16 1477 1479 O
medical 17 24 1480 1487 O
problem 25 32 1488 1495 O
in 33 35 1496 1498 O
addition 36 44 1499 1507 O
to 45 47 1508 1510 O
the 48 51 1511 1514 O
underlying 52 62 1515 1525 O
malignancy 63 73 1526 1536 B-cancer
and 74 77 1537 1540 O
organ 78 83 1541 1546 B-chronic_disease
dysfunction 84 95 1547 1558 I-chronic_disease
which 96 101 1559 1564 O
the 102 105 1565 1568 O
investigator 106 118 1569 1581 O
feels 119 124 1582 1587 O
would 125 130 1588 1593 O
pose 131 135 1594 1598 O
unacceptable 136 148 1599 1611 O
risk 149 153 1612 1616 O

Any 0 3 1617 1620 O
major 4 9 1621 1626 B-treatment
surgery 10 17 1627 1634 I-treatment
, 17 18 1634 1635 O
extensive 19 28 1636 1645 O
radiotherapy 29 41 1646 1658 B-treatment
, 41 42 1658 1659 O
chemotherapy 43 55 1660 1672 B-treatment
with 56 60 1673 1677 I-treatment
delayed 61 68 1678 1685 I-treatment
toxicity 69 77 1686 1694 I-treatment
, 77 78 1694 1695 O
biologic 79 87 1696 1704 B-treatment
therapy 88 95 1705 1712 I-treatment
, 95 96 1712 1713 O
or 97 99 1714 1716 O
immunotherapy 100 113 1717 1730 B-treatment
within 114 120 1731 1737 O
28 121 123 1738 1740 B-upper_bound
days 124 128 1741 1745 I-upper_bound
prior 129 134 1746 1751 I-upper_bound
to 135 137 1752 1754 O
enrollment 138 148 1755 1765 O
and/or 149 155 1766 1772 O
daily 156 161 1773 1778 O
or 162 164 1779 1781 O
weekly 165 171 1782 1788 O
chemotherapy 172 184 1789 1801 O
without 185 192 1802 1809 O
the 193 196 1810 1813 O
potential 197 206 1814 1823 O
for 207 210 1824 1827 O
delayed 211 218 1828 1835 O
toxicity 219 227 1836 1844 O
within 228 234 1845 1851 O
14 235 237 1852 1854 B-upper_bound
days 238 242 1855 1859 I-upper_bound
prior 243 248 1860 1865 I-upper_bound
to 249 251 1866 1868 O
enrollment 252 262 1869 1879 O

BRAF 0 4 1880 1884 O
V600E 5 10 1885 1890 O
melanoma 11 19 1891 1899 B-cancer
patients 20 28 1900 1908 O
who 29 32 1909 1912 O
have 33 37 1913 1917 O
failed 38 44 1918 1924 O
BRAF 45 49 1925 1929 B-treatment
inhibitors 50 60 1930 1940 I-treatment

Because 0 7 1941 1948 O
the 8 11 1949 1952 O
composition 12 23 1953 1964 O
, 23 24 1964 1965 O
PK 25 27 1966 1968 O
, 27 28 1968 1969 O
and 29 32 1970 1973 O
metabolism 33 43 1974 1984 O
of 44 46 1985 1987 O
many 47 51 1988 1992 O
herbal 52 58 1993 1999 B-treatment
supplements 59 70 2000 2011 I-treatment
are 71 74 2012 2015 O
unknown 75 82 2016 2023 O
, 82 83 2023 2024 O
the 84 87 2025 2028 O
concurrent 88 98 2029 2039 O
use 99 102 2040 2043 O
of 103 105 2044 2046 O
all 106 109 2047 2050 O
herbal 110 116 2051 2057 O
supplements 117 128 2058 2069 O
is 129 131 2070 2072 O
prohibited 132 142 2073 2083 O
during 143 149 2084 2090 O
the 150 153 2091 2094 O
study 154 159 2095 2100 O
( 160 161 2101 2102 O
including 161 170 2102 2111 O
, 170 171 2111 2112 O
but 172 175 2113 2116 O
not 176 179 2117 2120 O
limited 180 187 2121 2128 O
to 188 190 2129 2131 O
, 190 191 2131 2132 O
St. 192 195 2133 2136 B-treatment
John 196 200 2137 2141 I-treatment
's 200 202 2141 2143 I-treatment
wort 203 207 2144 2148 I-treatment
, 207 208 2148 2149 O
kava 209 213 2150 2154 B-treatment
, 213 214 2154 2155 O
ephedra 215 222 2156 2163 B-treatment
[ 223 224 2164 2165 I-treatment
ma 224 226 2165 2167 I-treatment
huang 227 232 2168 2173 I-treatment
] 232 233 2173 2174 I-treatment
, 233 234 2174 2175 O
ginkgo 235 241 2176 2182 B-treatment
biloba 242 248 2183 2189 I-treatment
, 248 249 2189 2190 O
dehydroepiandrosterone 250 272 2191 2213 B-treatment
[ 273 274 2214 2215 I-treatment
DHEA 274 278 2215 2219 I-treatment
] 278 279 2219 2220 I-treatment
, 279 280 2220 2221 O
yohimbe 281 288 2222 2229 B-treatment
, 288 289 2229 2230 O
saw 290 293 2231 2234 B-treatment
palmetto 294 302 2235 2243 I-treatment
, 302 303 2243 2244 O
or 304 306 2245 2247 O
ginseng 307 314 2248 2255 B-treatment
) 314 315 2255 2256 O

Colorectal 0 10 2257 2267 B-cancer
cancer 11 17 2268 2274 I-cancer
patients 18 26 2275 2283 O

Concurrent 0 10 2284 2294 B-treatment
treatment 11 20 2295 2304 I-treatment
with 21 25 2305 2309 I-treatment
bisphosphonates 26 41 2310 2325 I-treatment
is 42 44 2326 2328 O
permitted 45 54 2329 2338 O
; 54 55 2338 2339 O
however 56 63 2340 2347 O
, 63 64 2347 2348 O
treatment 65 74 2349 2358 O
must 75 79 2359 2363 O
be 80 82 2364 2366 O
initiated 83 92 2367 2376 O
prior 93 98 2377 2382 O
to 99 101 2383 2385 O
the 102 105 2386 2389 O
first 106 111 2390 2395 O
dose 112 116 2396 2400 O
of 117 119 2401 2403 O
study 120 125 2404 2409 B-treatment
therapy 126 133 2410 2417 I-treatment
; 133 134 2417 2418 O
prophylactic 135 147 2419 2431 O
use 148 151 2432 2435 O
of 152 154 2436 2438 O
bisphosphonates 155 170 2439 2454 O
in 171 173 2455 2457 O
patients 174 182 2458 2466 O
without 183 190 2467 2474 O
bone 191 195 2475 2479 B-chronic_disease
disease 196 203 2480 2487 I-chronic_disease
is 204 206 2488 2490 O
not 207 210 2491 2494 O
permitted 211 220 2495 2504 O
, 220 221 2504 2505 O
except 222 228 2506 2512 O
for 229 232 2513 2516 O
the 233 236 2517 2520 O
treatment 237 246 2521 2530 O
of 247 249 2531 2533 O
osteoporosis 250 262 2534 2546 B-chronic_disease

Current 0 7 2547 2554 O
use 8 11 2555 2558 O
of 12 14 2559 2561 O
a 15 16 2562 2563 O
prohibited 17 27 2564 2574 O
medication 28 38 2575 2585 B-treatment

Eastern 0 7 2586 2593 B-clinical_variable
Cooperative 8 19 2594 2605 I-clinical_variable
Oncology 20 28 2606 2614 I-clinical_variable
Group 29 34 2615 2620 I-clinical_variable
( 35 36 2621 2622 I-clinical_variable
ECOG 36 40 2622 2626 I-clinical_variable
) 40 41 2626 2627 I-clinical_variable
performance 42 53 2628 2639 I-clinical_variable
status 54 60 2640 2646 I-clinical_variable
= 61 62 2647 2648 O
< 62 63 2648 2649 O
2 64 65 2650 2651 B-upper_bound
( 66 67 2652 2653 O
Karnofsky 67 76 2653 2662 B-clinical_variable
> 77 78 2663 2664 O
= 78 79 2664 2665 O
60 80 82 2666 2668 B-lower_bound
% 82 83 2668 2669 I-lower_bound
) 83 84 2669 2670 O

HIV 0 3 2671 2674 B-chronic_disease
- 3 4 2674 2675 O
positive 4 12 2675 2683 O
patients 13 21 2684 2692 O
on 22 24 2693 2695 O
combination 25 36 2696 2707 O
antiretroviral 37 51 2708 2722 B-treatment
therapy 52 59 2723 2730 I-treatment
are 60 63 2731 2734 O
ineligible 64 74 2735 2745 O
because 75 82 2746 2753 O
of 83 85 2754 2756 O
the 86 89 2757 2760 O
potential 90 99 2761 2770 O
for 100 103 2771 2774 O
pharmacokinetic 104 119 2775 2790 O
interactions 120 132 2791 2803 O
; 132 133 2803 2804 O
in 134 136 2805 2807 O
addition 137 145 2808 2816 O
, 145 146 2816 2817 O
these 147 152 2818 2823 O
patients 153 161 2824 2832 O
are 162 165 2833 2836 O
at 166 168 2837 2839 O
increased 169 178 2840 2849 O
risk 179 183 2850 2854 O
of 184 186 2855 2857 O
lethal 187 193 2858 2864 O
infections 194 204 2865 2875 B-chronic_disease
when 205 209 2876 2880 O
treated 210 217 2881 2888 O
with 218 222 2889 2893 O
marrow 223 229 2894 2900 B-treatment
- 229 230 2900 2901 I-treatment
suppressive 230 241 2901 2912 I-treatment
therapy 242 249 2913 2920 I-treatment
; 249 250 2920 2921 O
appropriate 251 262 2922 2933 O
studies 263 270 2934 2941 O
will 271 275 2942 2946 O
be 276 278 2947 2949 O
undertaken 279 289 2950 2960 O
in 290 292 2961 2963 O
patients 293 301 2964 2972 O
receiving 302 311 2973 2982 O
combination 312 323 2983 2994 O
antiretroviral 324 338 2995 3009 O
therapy 339 346 3010 3017 O
when 347 351 3018 3022 O
indicated 352 361 3023 3032 O

Have 0 4 3033 3037 O
a 5 6 3038 3039 O
known 7 12 3040 3045 O
immediate 13 22 3046 3055 O
or 23 25 3056 3058 O
delayed 26 33 3059 3066 O
hypersensitivity 34 50 3067 3083 O
reaction 51 59 3084 3092 O
or 60 62 3093 3095 O
idiosyncrasy 63 75 3096 3108 O
to 76 78 3109 3111 O
drugs 79 84 3112 3117 O
chemically 85 95 3118 3128 O
related 96 103 3129 3136 O
to 104 106 3137 3139 O
trametinib 107 117 3140 3150 B-allergy_name
or 118 120 3151 3153 O
excipients 121 131 3154 3164 B-allergy_name
or 132 134 3165 3167 O
to 135 137 3168 3170 O
dimethyl 138 146 3171 3179 B-allergy_name
sulfoxide 147 156 3180 3189 I-allergy_name
( 157 158 3190 3191 I-allergy_name
DMSO 158 162 3191 3195 I-allergy_name
) 162 163 3195 3196 I-allergy_name

Hemoglobin 0 10 3197 3207 B-clinical_variable
> 11 12 3208 3209 O
= 12 13 3209 3210 O
9 14 15 3211 3212 B-lower_bound
g 16 17 3213 3214 I-lower_bound
/ 17 18 3214 3215 I-lower_bound
dL 18 20 3215 3217 I-lower_bound

Hepatocellular 0 14 3218 3232 B-cancer
carcinoma 15 24 3233 3242 I-cancer
( 25 26 3243 3244 I-cancer
HCC 26 29 3244 3247 I-cancer
) 29 30 3247 3248 I-cancer
patients 31 39 3249 3257 O
are 40 43 3258 3261 O
not 44 47 3262 3265 O
required 48 56 3266 3274 O
to 57 59 3275 3277 O
have 60 64 3278 3282 O
histologically 65 79 3283 3297 O
or 80 82 3298 3300 O
cytologically 83 96 3301 3314 O
confirmed 97 106 3315 3324 O
malignancy 107 117 3325 3335 B-cancer
, 117 118 3335 3336 O
patients 119 127 3337 3345 O
are 128 131 3346 3349 O
considered 132 142 3350 3360 O
eligible 143 151 3361 3369 O
based 152 157 3370 3375 O
on 158 160 3376 3378 O
tumor 161 166 3379 3384 B-cancer
markers 167 174 3385 3392 O
and/or 175 181 3393 3399 O
imaging 182 189 3400 3407 O
assessment 190 200 3408 3418 O

History 0 7 3419 3426 O
of 8 10 3427 3429 O
acute 11 16 3430 3435 B-chronic_disease
coronary 17 25 3436 3444 I-chronic_disease
syndromes 26 35 3445 3454 I-chronic_disease
( 36 37 3455 3456 O
including 37 46 3456 3465 O
myocardial 47 57 3466 3476 B-chronic_disease
infarction 58 68 3477 3487 I-chronic_disease
and 69 72 3488 3491 O
unstable 73 81 3492 3500 B-chronic_disease
angina 82 88 3501 3507 I-chronic_disease
) 88 89 3507 3508 O
, 89 90 3508 3509 O
coronary 91 99 3510 3518 B-treatment
angioplasty 100 111 3519 3530 I-treatment
, 111 112 3530 3531 O
or 113 115 3532 3534 O
stenting 116 124 3535 3543 B-treatment
within 125 131 3544 3550 O
6 132 133 3551 3552 B-upper_bound
months 134 140 3553 3559 I-upper_bound
prior 141 146 3560 3565 I-upper_bound
to 147 149 3566 3568 O
randomization 150 163 3569 3582 O

History 0 7 3583 3590 O
of 8 10 3591 3593 O
another 11 18 3594 3601 O
malignancy 19 29 3602 3612 B-cancer

History 0 7 3613 3620 O
of 8 10 3621 3623 O
interstitial 11 23 3624 3636 B-chronic_disease
lung 24 28 3637 3641 I-chronic_disease
disease 29 36 3642 3649 I-chronic_disease
or 37 39 3650 3652 O
pneumonitis 40 51 3653 3664 B-chronic_disease

History 0 7 3665 3672 O
or 8 10 3673 3675 O
current 11 18 3676 3683 O
evidence 19 27 3684 3692 O
/ 27 28 3692 3693 O
risk 28 32 3693 3697 O
of 33 35 3698 3700 O
retinal 36 43 3701 3708 B-chronic_disease
vein 44 48 3709 3713 I-chronic_disease
occlusion 49 58 3714 3723 I-chronic_disease
( 59 60 3724 3725 I-chronic_disease
RVO 60 63 3725 3728 I-chronic_disease
) 63 64 3728 3729 I-chronic_disease

History 0 7 3730 3737 O
or 8 10 3738 3740 O
evidence 11 19 3741 3749 O
of 20 22 3750 3752 O
cardiovascular 23 37 3753 3767 B-chronic_disease
risk 38 42 3768 3772 O

History 0 7 3773 3780 O
or 8 10 3781 3783 O
evidence 11 19 3784 3792 O
of 20 22 3793 3795 O
current 23 30 3796 3803 O
> 31 32 3804 3805 O
= 32 33 3805 3806 O
class 34 39 3807 3812 B-lower_bound
II 40 42 3813 3815 I-lower_bound
congestive 43 53 3816 3826 B-chronic_disease
heart 54 59 3827 3832 I-chronic_disease
failure 60 67 3833 3840 I-chronic_disease
as 68 70 3841 3843 O
defined 71 78 3844 3851 O
by 79 81 3852 3854 O
the 82 85 3855 3858 O
New 86 89 3859 3862 B-clinical_variable
York 90 94 3863 3867 I-clinical_variable
Heart 95 100 3868 3873 I-clinical_variable
Association 101 112 3874 3885 I-clinical_variable
( 113 114 3886 3887 I-clinical_variable
NYHA 114 118 3887 3891 I-clinical_variable
) 118 119 3891 3892 I-clinical_variable
functional 120 130 3893 3903 O
classification 131 145 3904 3918 O
system 146 152 3919 3925 O

History 0 7 3926 3933 O
or 8 10 3934 3936 O
evidence 11 19 3937 3945 O
of 20 22 3946 3948 O
current 23 30 3949 3956 O
clinically 31 41 3957 3967 O
significant 42 53 3968 3979 O
uncontrolled 54 66 3980 3992 O
arrhythmias 67 78 3993 4004 B-chronic_disease
( 79 80 4005 4006 O
exception 80 89 4006 4015 O
: 89 90 4015 4016 O
patients 91 99 4017 4025 O
with 100 104 4026 4030 O
controlled 105 115 4031 4041 O
atrial 116 122 4042 4048 B-chronic_disease
fibrillation 123 135 4049 4061 I-chronic_disease
for 136 139 4062 4065 O
> 140 141 4066 4067 O
30 142 144 4068 4070 B-lower_bound
days 145 149 4071 4075 I-lower_bound
prior 150 155 4076 4081 I-lower_bound
to 156 158 4082 4084 O
randomization 159 172 4085 4098 O
are 173 176 4099 4102 O
eligible 177 185 4103 4111 O
) 185 186 4111 4112 O

International 0 13 4113 4126 B-clinical_variable
normalized 14 24 4127 4137 I-clinical_variable
ratio 25 30 4138 4143 I-clinical_variable
( 31 32 4144 4145 I-clinical_variable
INR 32 35 4145 4148 I-clinical_variable
) 35 36 4148 4149 I-clinical_variable
= 37 38 4150 4151 O
< 38 39 4151 4152 O
1.5 40 43 4153 4156 B-upper_bound
x 44 45 4157 4158 I-upper_bound
institutional 46 59 4159 4172 I-upper_bound
ULN 60 63 4173 4176 I-upper_bound

Known 0 5 4177 4182 O
cardiac 6 13 4183 4190 B-cancer
metastases 14 24 4191 4201 I-cancer

Left 0 4 4202 4206 B-clinical_variable
ventricular 5 16 4207 4218 I-clinical_variable
ejection 17 25 4219 4227 I-clinical_variable
fraction 26 34 4228 4236 I-clinical_variable
( 35 36 4237 4238 I-clinical_variable
LVEF 36 40 4238 4242 I-clinical_variable
) 40 41 4242 4243 I-clinical_variable
> 42 43 4244 4245 O
= 43 44 4245 4246 O
institutional 45 58 4247 4260 O
lower 59 64 4261 4266 O
limit 65 70 4267 4272 O
of 71 73 4273 4275 O
normal 74 80 4276 4282 O
( 81 82 4283 4284 O
LLN 82 85 4284 4287 O
) 85 86 4287 4288 O
by 87 89 4289 4291 O
echocardiogram 90 104 4292 4306 B-treatment
( 105 106 4307 4308 I-treatment
ECHO 106 110 4308 4312 I-treatment
) 110 111 4312 4313 I-treatment
or 112 114 4314 4316 O
multigated 115 125 4317 4327 B-treatment
acquisition 126 137 4328 4339 I-treatment
scan 138 142 4340 4344 I-treatment
( 143 144 4345 4346 I-treatment
MUGA 144 148 4346 4350 I-treatment
) 148 149 4350 4351 I-treatment

Life 0 4 4352 4356 B-clinical_variable
expectancy 5 15 4357 4367 I-clinical_variable
of 16 18 4368 4370 O
greater 19 26 4371 4378 O
than 27 31 4379 4383 O
3 32 33 4384 4385 B-lower_bound
months 34 40 4386 4392 I-lower_bound

No 0 2 4393 4395 O
distinction 3 14 4396 4407 O
should 15 21 4408 4414 O
be 22 24 4415 4417 O
made 25 29 4418 4422 O
between 30 37 4423 4430 O
liver 38 43 4431 4436 B-chronic_disease
dysfunction 44 55 4437 4448 I-chronic_disease
due 56 59 4449 4452 O
to 60 62 4453 4455 O
metastases 63 73 4456 4466 B-cancer
and 74 77 4467 4470 O
liver 78 83 4471 4476 O
dysfunction 84 95 4477 4488 O
due 96 99 4489 4492 O
to 100 102 4493 4495 O
other 103 108 4496 4501 O
causes 109 115 4502 4508 O

Other 0 5 4509 4514 O
anti 6 10 4515 4519 B-treatment
- 10 11 4519 4520 I-treatment
cancer 11 17 4520 4526 I-treatment
therapy 18 25 4527 4534 I-treatment
while 26 31 4535 4540 O
on 32 34 4541 4543 O
study 35 40 4544 4549 O
treatment 41 50 4550 4559 B-treatment

Pancreatic 0 10 4560 4570 B-cancer
cancer 11 17 4571 4577 I-cancer
patients 18 26 4578 4586 O

Partial 0 7 4587 4594 B-clinical_variable
thromboplastin 8 22 4595 4609 I-clinical_variable
time 23 27 4610 4614 I-clinical_variable
( 28 29 4615 4616 I-clinical_variable
PTT 29 32 4616 4619 I-clinical_variable
) 32 33 4619 4620 I-clinical_variable
= 34 35 4621 4622 O
< 35 36 4622 4623 O
1.5 37 40 4624 4627 B-upper_bound
x 41 42 4628 4629 I-upper_bound
institutional 43 56 4630 4643 I-upper_bound
ULN 57 60 4644 4647 I-upper_bound

Patients 0 8 4648 4656 O
must 9 13 4657 4661 O
have 14 18 4662 4666 O
a 19 20 4667 4668 O
histologically 21 35 4669 4683 O
or 36 38 4684 4686 O
cytologically 39 52 4687 4700 O
confirmed 53 62 4701 4710 O
solid 63 68 4711 4716 B-cancer
malignancy 69 79 4717 4727 I-cancer
that 80 84 4728 4732 O
is 85 87 4733 4735 O
metastatic 88 98 4736 4746 B-cancer
or 99 101 4747 4749 O
unresectable 102 114 4750 4762 O
for 115 118 4763 4766 O
which 119 124 4767 4772 O
standard 125 133 4773 4781 B-treatment
curative 134 142 4782 4790 I-treatment
or 143 145 4791 4793 I-treatment
palliative 146 156 4794 4804 I-treatment
treatments 157 167 4805 4815 I-treatment
do 168 170 4816 4818 O
not 171 174 4819 4822 O
exist 175 180 4823 4828 O
or 181 183 4829 4831 O
are 184 187 4832 4835 O
no 188 190 4836 4838 O
longer 191 197 4839 4845 O
effective 198 207 4846 4855 O

Patients 0 8 4856 4864 O
with 9 13 4865 4869 O
active 14 20 4870 4876 O
hemolysis 21 30 4877 4886 B-chronic_disease

Patients 0 8 4887 4895 O
with 9 13 4896 4900 O
intra 14 19 4901 4906 O
- 19 20 4906 4907 O
cardiac 20 27 4907 4914 O
defibrillators 28 42 4915 4929 B-treatment

Patients 0 8 4930 4938 O
with 9 13 4939 4943 O
pancreatic 14 24 4944 4954 B-cancer
cancer 25 31 4955 4961 I-cancer
, 31 32 4961 4962 O
colorectal 33 43 4963 4973 B-cancer
cancer 44 50 4974 4980 I-cancer
, 50 51 4980 4981 O
and 52 55 4982 4985 O
BRAF 56 60 4986 4990 O
V600E 61 66 4991 4996 O
melanoma 67 75 4997 5005 B-cancer
patients 76 84 5006 5014 O
who 85 88 5015 5018 O
have 89 93 5019 5023 O
failed 94 100 5024 5030 O
BRAF 101 105 5031 5035 B-treatment
inhibitors 106 116 5036 5046 I-treatment
are 117 120 5047 5050 O
allowed 121 128 5051 5058 O
to 129 131 5059 5061 O
enroll 132 138 5062 5068 O
in 139 141 5069 5071 O
the 142 145 5072 5075 O
moderate 146 154 5076 5084 O
and 155 158 5085 5088 O
severe 159 165 5089 5095 O
cohorts 166 173 5096 5103 O
provided 174 182 5104 5112 O
the 183 186 5113 5116 O
patients 187 195 5117 5125 O
: 195 196 5125 5126 O
1 197 198 5127 5128 O
) 198 199 5128 5129 O
sign 200 204 5130 5134 O
a 205 206 5135 5136 O
separate 207 215 5137 5145 O
consent 216 223 5146 5153 O
form 224 228 5154 5158 O
which 229 234 5159 5164 O
outlines 235 243 5165 5173 O
the 244 247 5174 5177 O
extremely 248 257 5178 5187 O
limited 258 265 5188 5195 O
activity 266 274 5196 5204 O
observed 275 283 5205 5213 O
in 284 286 5214 5216 O
prior 287 292 5217 5222 O
studies 293 300 5223 5230 O
, 300 301 5230 5231 O
and 302 305 5232 5235 O
2 306 307 5236 5237 O
) 307 308 5237 5238 O
are 309 312 5239 5242 O
consented 313 322 5243 5252 O
to 323 325 5253 5255 O
the 326 329 5256 5259 O
study 330 335 5260 5265 O
by 336 338 5266 5268 O
a 339 340 5269 5270 O
protocol 341 349 5271 5279 O
- 349 350 5279 5280 O
specified 350 359 5280 5289 O
designee 360 368 5290 5298 O
who 369 372 5299 5302 O
is 373 375 5303 5305 O
not 376 379 5306 5309 O
their 380 385 5310 5315 O
longitudinal 386 398 5316 5328 O
oncologist 399 409 5329 5339 O

Platelets 0 9 5340 5349 B-clinical_variable
> 10 11 5350 5351 O
= 11 12 5351 5352 O
75 13 15 5353 5355 B-lower_bound
x 16 17 5356 5357 I-lower_bound
10 18 20 5358 5360 I-lower_bound
^ 20 21 5360 5361 I-lower_bound
9 21 22 5361 5362 I-lower_bound
/ 22 23 5362 5363 I-lower_bound
L 23 24 5363 5364 I-lower_bound

Proteinuria 0 11 5365 5376 B-clinical_variable
= 12 13 5377 5378 O
< 13 14 5378 5379 O
+1 15 17 5380 5382 O
on 18 20 5383 5385 O
dipstick 21 29 5386 5394 O
or 30 32 5395 5397 O
= 33 34 5398 5399 O
< 34 35 5399 5400 O
1 36 37 5401 5402 B-upper_bound
gram/24 38 45 5403 5410 I-upper_bound
hours 46 51 5411 5416 I-upper_bound

Prothrombin 0 11 5417 5428 B-clinical_variable
time 12 16 5429 5433 I-clinical_variable
( 17 18 5434 5435 I-clinical_variable
PT 18 20 5435 5437 I-clinical_variable
) 20 21 5437 5438 I-clinical_variable
= 22 23 5439 5440 O
< 23 24 5440 5441 O
1.5 25 28 5442 5445 B-upper_bound
x 29 30 5446 5447 I-upper_bound
institutional 31 44 5448 5461 I-upper_bound
upper 45 50 5462 5467 I-upper_bound
limit 51 56 5468 5473 I-upper_bound
of 57 59 5474 5476 I-upper_bound
normal 60 66 5477 5483 I-upper_bound
( 67 68 5484 5485 I-upper_bound
ULN 68 71 5485 5488 I-upper_bound
) 71 72 5488 5489 I-upper_bound

Serum 0 5 5490 5495 B-clinical_variable
creatinine 6 16 5496 5506 I-clinical_variable
= 17 18 5507 5508 O
< 18 19 5508 5509 O
1.5 20 23 5510 5513 B-upper_bound
mg 24 26 5514 5516 I-upper_bound
/ 26 27 5516 5517 I-upper_bound
dL 27 29 5517 5519 I-upper_bound
(= 30 32 5520 5522 O
< 32 33 5522 5523 O
133 34 37 5524 5527 B-upper_bound
umol 38 42 5528 5532 I-upper_bound
/ 42 43 5532 5533 I-upper_bound
L 43 44 5533 5534 I-upper_bound
) 44 45 5534 5535 O
OR 46 48 5536 5538 O
calculated 49 59 5539 5549 B-clinical_variable
creatinine 60 70 5550 5560 I-clinical_variable
clearance 71 80 5561 5570 I-clinical_variable
( 81 82 5571 5572 O
Cockcroft 82 91 5572 5581 B-clinical_variable
- 91 92 5581 5582 I-clinical_variable
Gault 92 97 5582 5587 I-clinical_variable
formula 98 105 5588 5595 I-clinical_variable
) 105 106 5595 5596 O
> 107 108 5597 5598 O
= 108 109 5598 5599 O
50 110 112 5600 5602 B-lower_bound
mL 113 115 5603 5605 I-lower_bound
/ 115 116 5605 5606 I-lower_bound
min 116 119 5606 5609 I-lower_bound
OR 120 122 5610 5612 O
24 123 125 5613 5615 O
- 125 126 5615 5616 O
hour 126 130 5616 5620 O
urine 131 136 5621 5626 O
creatinine 137 147 5627 5637 O
clearance 148 157 5638 5647 O
> 158 159 5648 5649 O
= 159 160 5649 5650 O
50 161 163 5651 5653 O
mL 164 166 5654 5656 O
/ 166 167 5656 5657 O
min 167 170 5657 5660 O

Symptomatic 0 11 5661 5672 O
or 12 14 5673 5675 O
untreated 15 24 5676 5685 B-cancer
leptomeningeal 25 39 5686 5700 I-cancer
or 40 42 5701 5703 O
brain 43 48 5704 5709 B-cancer
metastases 49 59 5710 5720 I-cancer
or 60 62 5721 5723 O
spinal 63 69 5724 5730 B-chronic_disease
cord 70 74 5731 5735 I-chronic_disease
compression 75 86 5736 5747 I-chronic_disease

Trametinib 0 10 5748 5758 B-treatment
can 11 14 5759 5762 O
cause 15 20 5763 5768 O
fetal 21 26 5769 5774 O
harm 27 31 5775 5779 O
when 32 36 5780 5784 O
administered 37 49 5785 5797 O
to 50 52 5798 5800 O
a 53 54 5801 5802 O
pregnant 55 63 5803 5811 O
woman 64 69 5812 5817 B-gender
; 69 70 5817 5818 O
women 71 76 5819 5824 B-gender
of 77 79 5825 5827 O
child 80 85 5828 5833 O
- 85 86 5833 5834 O
bearing 86 93 5834 5841 O
potential 94 103 5842 5851 O
and 104 107 5852 5855 O
men 108 111 5856 5859 O
must 112 116 5860 5864 O
agree 117 122 5865 5870 B-contraception_consent
to 123 125 5871 5873 I-contraception_consent
use 126 129 5874 5877 I-contraception_consent
adequate 130 138 5878 5886 I-contraception_consent
contraception 139 152 5887 5900 I-contraception_consent
( 153 154 5901 5902 O
hormonal 154 162 5902 5910 B-chronic_disease
or 163 165 5911 5913 O
barrier 166 173 5914 5921 B-contraception_consent
method 174 180 5922 5928 I-contraception_consent
of 181 183 5929 5931 I-contraception_consent
birth 184 189 5932 5937 I-contraception_consent
control 190 197 5938 5945 I-contraception_consent
; 197 198 5945 5946 O
abstinence 199 209 5947 5957 B-contraception_consent
) 209 210 5957 5958 O
prior 211 216 5959 5964 O
to 217 219 5965 5967 O
study 220 225 5968 5973 O
entry 226 231 5974 5979 O
, 231 232 5979 5980 O
during 233 239 5981 5987 O
the 240 243 5988 5991 O
study 244 249 5992 5997 O
participation 250 263 5998 6011 O
, 263 264 6011 6012 O
and 265 268 6013 6016 O
for 269 272 6017 6020 O
four 273 277 6021 6025 B-upper_bound
months 278 284 6026 6032 I-upper_bound
after 285 290 6033 6038 I-upper_bound
the 291 294 6039 6042 O
last 295 299 6043 6047 O
dose 300 304 6048 6052 O
of 305 307 6053 6055 O
the 308 311 6056 6059 O
drug 312 316 6060 6064 O
; 316 317 6064 6065 O
women 318 323 6066 6071 O
of 324 326 6072 6074 O
child 327 332 6075 6080 O
- 332 333 6080 6081 O
bearing 333 340 6081 6088 O
potential 341 350 6089 6098 O
must 351 355 6099 6103 O
have 356 360 6104 6108 O
a 361 362 6109 6110 O
negative 363 371 6111 6119 B-pregnancy
serum 372 377 6120 6125 I-pregnancy
pregnancy 378 387 6126 6135 I-pregnancy
test 388 392 6136 6140 O
within 393 399 6141 6147 O
14 400 402 6148 6150 B-upper_bound
days 403 407 6151 6155 I-upper_bound
prior 408 413 6156 6161 I-upper_bound
to 414 416 6162 6164 O
registration 417 429 6165 6177 O
and 430 433 6178 6181 O
agree 434 439 6182 6187 B-contraception_consent
to 440 442 6188 6190 I-contraception_consent
use 443 446 6191 6194 I-contraception_consent
effective 447 456 6195 6204 I-contraception_consent
contraception 457 470 6205 6218 I-contraception_consent
throughout 471 481 6219 6229 O
the 482 485 6230 6233 O
treatment 486 495 6234 6243 B-treatment
period 496 502 6244 6250 O
and 503 506 6251 6254 O
for 507 510 6255 6258 O
4 511 512 6259 6260 B-upper_bound
months 513 519 6261 6267 I-upper_bound
after 520 525 6268 6273 I-upper_bound
the 526 529 6274 6277 O
last 530 534 6278 6282 O
dose 535 539 6283 6287 O
of 540 542 6288 6290 O
study 543 548 6291 6296 O
treatment 549 558 6297 6306 O
; 558 559 6306 6307 O
should 560 566 6308 6314 O
a 567 568 6315 6316 O
woman 569 574 6317 6322 O
become 575 581 6323 6329 B-pregnancy
pregnant 582 590 6330 6338 I-pregnancy
or 591 593 6339 6341 O
suspect 594 601 6342 6349 O
she 602 605 6350 6353 O
is 606 608 6354 6356 O
pregnant 609 617 6357 6365 O
while 618 623 6366 6371 O
she 624 627 6372 6375 O
or 628 630 6376 6378 O
her 631 634 6379 6382 O
partner 635 642 6383 6390 O
is 643 645 6391 6393 O
participating 646 659 6394 6407 O
in 660 662 6408 6410 O
this 663 667 6411 6415 O
study 668 673 6416 6421 O
, 673 674 6421 6422 O
she 675 678 6423 6426 O
should 679 685 6427 6433 O
inform 686 692 6434 6440 O
her 693 696 6441 6444 O
treating 697 705 6445 6453 O
physician 706 715 6454 6463 O
immediately 716 727 6464 6475 O

Treatment 0 9 6476 6485 B-chronic_disease
- 9 10 6485 6486 I-chronic_disease
refractory 10 20 6486 6496 I-chronic_disease
hypertension 21 33 6497 6509 I-chronic_disease
defined 34 41 6510 6517 O
as 42 44 6518 6520 O
a 45 46 6521 6522 O
blood 47 52 6523 6528 B-clinical_variable
pressure 53 61 6529 6537 I-clinical_variable
of 62 64 6538 6540 I-clinical_variable
systolic 65 73 6541 6549 I-clinical_variable
> 74 75 6550 6551 O
140 76 79 6552 6555 B-lower_bound
mmHg 80 84 6556 6560 I-lower_bound
and/or 85 91 6561 6567 O
diastolic 92 101 6568 6577 B-clinical_variable
> 102 103 6578 6579 O
90 104 106 6580 6582 B-lower_bound
mmHg 107 111 6583 6587 I-lower_bound
which 112 117 6588 6593 O
can 118 121 6594 6597 O
not 121 124 6597 6600 O
be 125 127 6601 6603 O
controlled 128 138 6604 6614 O
by 139 141 6615 6617 O
anti 142 146 6618 6622 B-treatment
- 146 147 6622 6623 I-treatment
hypertensive 147 159 6623 6635 I-treatment
therapy 160 167 6636 6643 I-treatment

Uncontrolled 0 12 6644 6656 O
intercurrent 13 25 6657 6669 B-chronic_disease
illness 26 33 6670 6677 I-chronic_disease
including 34 43 6678 6687 O
, 43 44 6687 6688 O
but 45 48 6689 6692 O
not 49 52 6693 6696 O
limited 53 60 6697 6704 O
to 61 63 6705 6707 O
, 63 64 6707 6708 O
ongoing 65 72 6709 6716 O
or 73 75 6717 6719 O
active 76 82 6720 6726 B-chronic_disease
infection 83 92 6727 6736 I-chronic_disease
, 92 93 6736 6737 O
symptomatic 94 105 6738 6749 O
congestive 106 116 6750 6760 B-chronic_disease
heart 117 122 6761 6766 I-chronic_disease
failure 123 130 6767 6774 I-chronic_disease
, 130 131 6774 6775 O
unstable 132 140 6776 6784 O
angina 141 147 6785 6791 B-chronic_disease
pectoris 148 156 6792 6800 I-chronic_disease
, 156 157 6800 6801 O
cardiac 158 165 6802 6809 O
arrhythmia 166 176 6810 6820 B-chronic_disease
, 176 177 6820 6821 O
or 178 180 6822 6824 O
psychiatric 181 192 6825 6836 B-chronic_disease
illness 193 200 6837 6844 I-chronic_disease
/ 200 201 6844 6845 O
social 201 207 6845 6851 O
situations 208 218 6852 6862 O
that 219 223 6863 6867 O
would 224 229 6868 6873 O
limit 230 235 6874 6879 O
compliance 236 246 6880 6890 O
with 247 251 6891 6895 O
study 252 257 6896 6901 O
requirements 258 270 6902 6914 O

Use 0 3 6915 6918 O
of 4 6 6919 6921 O
other 7 12 6922 6927 O
investigational 13 28 6928 6943 B-treatment
drugs 29 34 6944 6949 I-treatment
within 35 41 6950 6956 O
28 42 44 6957 6959 B-upper_bound
days 45 49 6960 6964 I-upper_bound
( 50 51 6965 6966 O
or 51 53 6966 6968 O
five 54 58 6969 6973 B-upper_bound
half 59 63 6974 6978 I-upper_bound
- 63 64 6978 6979 I-upper_bound
lives 64 69 6979 6984 I-upper_bound
, 69 70 6984 6985 O
whichever 71 80 6986 6995 O
is 81 83 6996 6998 O
shorter 84 91 6999 7006 O
; 91 92 7006 7007 O
with 93 97 7008 7012 O
a 98 99 7013 7014 O
minimum 100 107 7015 7022 O
of 108 110 7023 7025 O
14 111 113 7026 7028 B-lower_bound
days 114 118 7029 7033 I-lower_bound
from 119 123 7034 7038 O
the 124 127 7039 7042 O
last 128 132 7043 7047 O
dose 133 137 7048 7052 O
) 137 138 7052 7053 O
preceding 139 148 7054 7063 O
the 149 152 7064 7067 O
first 153 158 7068 7073 O
dose 159 163 7074 7078 O
of 164 166 7079 7081 O
trametinib 167 177 7082 7092 B-treatment
and 178 181 7093 7096 O
during 182 188 7097 7103 O
the 189 192 7104 7107 O
study 193 198 7108 7113 O
; 198 199 7113 7114 O
patients 200 208 7115 7123 O
previously 209 219 7124 7134 O
treated 220 227 7135 7142 O
with 228 232 7143 7147 O
v 233 234 7148 7149 B-treatment
- 234 235 7149 7150 I-treatment
raf 235 238 7150 7153 I-treatment
murine 239 245 7154 7160 I-treatment
sarcoma 246 253 7161 7168 I-treatment
( 254 255 7169 7170 I-treatment
RAF 255 258 7170 7173 I-treatment
) 258 259 7173 7174 I-treatment
and/or 260 266 7175 7181 O
mitogen 267 274 7182 7189 B-treatment
- 274 275 7189 7190 I-treatment
activated 275 284 7190 7199 I-treatment
protein 285 292 7200 7207 I-treatment
kinase 293 299 7208 7214 I-treatment
( 300 301 7215 7216 I-treatment
MEK 301 304 7216 7219 I-treatment
) 304 305 7219 7220 I-treatment
inhibitors 306 316 7221 7231 I-treatment

multikinase 0 11 7232 7243 B-treatment
antiangiogenic 12 26 7244 7258 I-treatment
tyrosine 27 35 7259 7267 I-treatment
kinase 36 42 7268 7274 I-treatment
inhibitors 43 53 7275 7285 I-treatment
such 54 58 7286 7290 O
as 59 61 7291 7293 O
regorafenib 62 73 7294 7305 B-treatment
, 73 74 7305 7306 O
sorafenib 75 84 7307 7316 B-treatment
, 84 85 7316 7317 O
sunitinib 86 95 7318 7327 B-treatment
, 95 96 7327 7328 O
etc 97 100 7329 7332 O
. 100 101 7332 7333 O
whose 102 107 7334 7339 O
primary 108 115 7340 7347 O
mechanism 116 125 7348 7357 O
of 126 128 7358 7360 O
action 129 135 7361 7367 O
is 136 138 7368 7370 O
not 139 142 7371 7374 O
RAF 143 146 7375 7378 B-treatment
inhibition 147 157 7379 7389 I-treatment

patients 0 8 7390 7398 O
with 9 13 7399 7403 O
chronic 14 21 7404 7411 O
or 22 24 7412 7414 O
cleared 25 32 7415 7422 O
HBV 33 36 7423 7426 B-chronic_disease
and 37 40 7427 7430 O
HCV 41 44 7431 7434 B-chronic_disease
infection 45 54 7435 7444 I-chronic_disease

